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T
he term “epigenetics” was 
ﬁ  rst proposed by Conrad 
Waddington to designate the 
study of the processes by which the 
genetic information of an organism, 
deﬁ  ned as genotype, interacts with the 
environment in order to produce its 
observed traits, deﬁ  ned as phenotype 
[1]. More recently, the term has been 
used to describe heritable changes in 
genome function that occur without a 
change in DNA sequence [2]. These 
two deﬁ  nitions are closer than they 
seem. In eukaryotic cells, genomic 
DNA is packaged by histones and 
non-histone proteins into a dynamic 
polymer deﬁ  ned as chromatin. Several 
enzymes can modify the architecture 
and the composition of chromatin, 
both locally and globally, and they 
can direct the inheritance of local 
chromatin structures through cell 
division [3,4]. Thus, an individual’s 
cells all share the same linear sequence 
of DNA nucleotides—the genome—but 
different cell types are characterized 
by the presence of different 
chromatin ﬂ  avors of this genome—
the epigenomes—that specify the 
characteristic functions of each cell 
type and allow the maintenance of the 
memory of these functions through cell 
division. Indeed, a large set of genome 
regulatory processes involve epigenetic 
determination and inheritance.
Because of the vast complexity 
of epigenetic regulation, ranging 
from single genes to the folding of 
whole chromosomes in the nucleus, 
epigenetics involves an amazingly 
wide spectrum of techniques and 
approaches. These involve structural, 
molecular, and developmental 
biology, advanced imaging, genomics, 
proteomics, bioinformatics, and 
mathematical analysis. Epigenetic 
research is applied to different 
organisms, and it often includes 
comparative analysis from an 
evolutionary perspective. Researchers 
in this ﬁ  eld must thus cross borders 
between different research areas in 
order to understand the impact of 
novel ﬁ  ndings. This makes epigenetics 
a highly dynamic area of research, one 
that at the same time provides an ideal 
ground for collaborative and synergistic 
interactions.
With the support of the Sixth 
Framework Programme of the 
European Union, a consortium of 
25 core laboratories and 26 associate 
laboratories initiated the Epigenome 
Network of Excellence (NoE) in 2004. 
This network will tackle key questions 
in epigenetic research, integrate young 
research teams in Europe, provide 
the scientiﬁ  c community with a large 
spectrum of resources, including Web-
based information, and disseminate 
scientiﬁ  c knowledge to scientists, 
students, and the wider public. The 
Epigenome NoE coordinator, Thomas 
Jenuwein, says “Epigenetic research 
represents one of the new frontiers 
in modern biology with considerable 
impact on many basic mechanisms and 
on human biology and disease. With 
this NoE, the European Commission 
has allowed the afﬁ  liated network 
members to establish a coherent 
framework for promoting this exciting 
research area also to non-members 
and to interested colleagues outside 
the ﬁ  eld. I am convinced that the 
enthusiastic spirit of the kick-off 
meeting at the Mendel Abbey in Brno 
(September 2004) has inspired many 
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Figure 1. The Impact of Epigenetic Gene Control
Diverse biochemical modiﬁ  cations of DNA and histones, such as DNA methylation 
(indicated by small hexagons), histone methylation (large hexagons), acetylation 
(triangles), and phosphorylation (circles), occur in response to the environment and 
modulate chromatin structure. The organization of chromatin controls the access of 
many proteins, including transcription factors (ovals), to the DNA template and thus 
regulates gene expression. This epigenetic gene control has an impact on a variety of 
biological processes, with implications for agriculture and human biology and disease, 
including our understanding of stem cells, cancer, and aging.PLoS Biology  |  www.plosbiology.org 0763
positive and long-lasting signals for 
a highly functional and integrative 
network all across Europe.”
The Epigenome NoE has four 
main aims. The ﬁ  rst is to advance 
scientiﬁ  c discoveries via a strong joint 
programme of activities, of which a 
large part is dedicated to research 
carried out by member labs, alone or 
in collaboration. These projects range 
from chromatin modiﬁ  cation to cell 
fate and disease and address some 
of the “big questions” in epigenetic 
research (Figure 1).
The second aim is to integrate young 
researchers into the network via a 
programme called Newly Established 
Teams (NET). NET provides funding 
for research and integration in the 
joint activity programme to promising 
junior investigators. Newly established 
researchers often struggle to acquire 
lab funding, establish collaborations, 
or simply gather information on 
available resources in the ﬁ  eld. The 
NET programme provides an ideal 
platform for such investigators by 
generating a collaborative atmosphere 
and opportunities for setting up 
joint projects and obtaining top-level 
biochemical and genomic reagents as 
well as access to state-of-the-art genomic 
and proteomic facilities. The more 
established NoE members also act 
as mentors for the NET participants. 
In a ﬁ  rst wave of integration, twelve 
NET investigators were selected by an 
external advisory board (comprising 
seven United States scientists who are 
world leaders in epigenetic research) 
and participated in the kick-off 
meeting. A second call to integrate ten 
more NET members will be launched 
in 2006, advertised towards the end of 
this year through the Epigenome NoE 
Web site (http:⁄⁄www.epigenome-noe.
net). This call will complete the NET 
programme for the ﬁ  ve-year funding 
period of this NoE. If successful, this 
type of integrated effort may serve 
as an example for future large-scale 
collaborative projects. The network 
is gearing up to maintain its funding 
in the longer term, so that it can 
continue attracting future generations 
of top-level young European scientists 
to epigenetics. Jacques Remacle, 
EU Commission Scientiﬁ  c Ofﬁ  cer, 
says “To foster research progress in 
epigenetics, the Epigenome NoE will 
have to maintain a dynamic structure 
involving also the participation and 
integration of newly established 
research teams. By its ﬂ  exible nature, 
the Network of Excellence instrument 
allows the consortia to evolve over the 
time to meet new research challenges 
and/or to promote openness, 
expansion and durability. The new 12 
NET [investigators] that are joining 
the Epigenome NoE following an 
open call (57 applications) and a 
transparent selection process are 
all of outstanding quality. I strongly 
believe that their participation and 
integration to the Epigenome NoE 
project will beneﬁ  t epigenetic research 
in Europe. Following this successful 
example, the concept of open call for 
young investigators is now promoted by 
several NoEs in other research areas.”
A third aim of the network is to 
provide the scientiﬁ  c community with a 
large set of resources and information 
in epigenetic research, and to centralize 
access to the information already 
available from existing sources. The 
key to this aim is the Epigenome NoE 
Web site (http://www.epigenome-noe.
net). During 2005, the site will grow 
in its role as a database of technology 
and resources available in individual 
labs and institutions. Any scientist 
external to the network will have the 
chance to establish collaborations with 
NoE members and thus to access these 
resources. Furthermore, the Web site 
is being augmented with searchable 
databases of experimental protocols, 
laboratory proﬁ  les, and relevant 
conferences and courses. Interactive 
Web forums for discussion of each 
resource and other hot topics in the 
ﬁ  eld of epigenetics will be opened, 
and job opportunities will be posted 
regularly. This Web site is therefore 
expected to become a major source of 
information for epigenetic researchers.
A fourth aim of the Epigenome 
NoE is to have annual meetings 
and workshops that are organized 
around speciﬁ  c research topics, 
which will foster collaborations that 
are likely to be as important, if not 
more important, than the funding 
initiative itself. The NoE also aims 
at reaching the wider scientiﬁ  c 
community and the public, bringing 
the concept and the importance of 
epigenetics to their attention, and 
raising the level of awareness of the 
major impact of epigenetic research 
in important areas such as agriculture 
and medicine. This will be achieved 
by organizing public scientiﬁ  c events, 
by publishing material written in 
lay language that reviews speciﬁ  c 
subjects of particular interest, by 
setting up a Web information service 
on epigenetics and genomics, and by 
maintaining an updated “Frequently 
Asked Questions” Web site. An 
education page is already posted, 
which contains a large collection 
of Web teaching material on issues 
related to epigenetics. Educational 
materials developed in house will be 
added here in the future. The public 
science component in this NoE should 
enable us to communicate both the 
beauty of the underlying scientiﬁ  c 
questions as well as the signiﬁ  cant 
medical and ethical relevance of 
epigenetics to the general public, thus 
bridging a gap between scientists and 
society. Genetics is becoming deeply 
rooted in the cultural foundations 
of modern societies. Epigenetics is 
equally important, and thanks to the 
activities of the Epigenome NoE, this 
relatively new branch of science may 
soon become familiar to a much wider 
audience.  
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